Vir Biotechnology VIR
NASDAQ VIR
$11.17 -0.12 (-1.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Price to Earnings (2021 - 2022)

Updated

Vir Biotechnology's Price to Earnings was 6.54 in Q4 2022, down 37.1% from 10.39 a year earlier but up 191.3% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Price to Earnings (2021 - 2022) Analysis & Trends

From Q4 2021 onward, Vir Biotechnology has reported Price to Earnings for 5 quarters.

  • In earlier years, Price to Earnings was 10.39 in FY2021.
  • Quarterly Price to Earnings has moved between 2.24 (Q3 2022) and 10.39 (Q4 2021) over five years.
  • Per Business Quant data, VIR's Price to Earnings in the three quarters before Q4 2022 was 2.24 (Q3 2022), 3.13 (Q2 2022) and 2.80 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 6.54
Sep 30, 2022 2.24
Jun 30, 2022 3.13
Mar 31, 2022 2.80
Dec 31, 2021 10.39
API Access

Vir Biotechnology Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=VIR&period=max&api_key=YOUR_API_KEY